Results 31 to 40 of about 34,194 (287)

The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1low Mice

open access: yesFrontiers in Oncology, 2022
A major role for human (h)CXCL8 (interleukin-8) in the pathobiology of myelofibrosis (MF) has been suggested by observations indicating that MF megakaryocytes express increased levels of hCXCL8 and that plasma levels of this cytokine in MF patients are ...
Paola Verachi   +17 more
doaj   +1 more source

Platelets, Not an Insignificant Player in Development of Allergic Asthma

open access: yesCells, 2021
Allergic asthma is a chronic and heterogeneous pulmonary disease in which platelets can be activated in an IgE-mediated pathway and migrate to the airways via CCR3-dependent mechanism.
Liping Luo   +3 more
doaj   +1 more source

Salicylate Inhibits Thrombopoiesis in Rat Megakaryocytes by Changing the Membrane Micro-Architecture

open access: yesCellular Physiology and Biochemistry, 2015
Background/Aims: Salicylate causes drug-induced immune thrombocytopenia. However, some clinical studies indicate the presence of additional mechanisms in the drug-induced thrombocytopenia, by which the platelet production from megakaryocytes may directly
Itsuro Kazama   +6 more
doaj   +1 more source

Megakaryocytes - 1

open access: yes, 2010
An image from a bone marrow direct smear under 10X magnification showing multiple megakaryocytes in the tail of the ...
Fraser, Marion
core   +1 more source

Classical Complement Pathway Inhibition in a Pediatric Patient With Refractory Immune Thrombocytopenia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric refractory immune thrombocytopenia (rITP) is generally characterized by persistent thrombocytopenia and failure to achieve a sustained response to multiple standard therapies. We report a 4‐year‐old female with congenital tufting enteropathy, post‐intestinal transplant patient on immunosuppressants, who developed severe rITP ...
Sarah Hsieh   +4 more
wiley   +1 more source

Megakaryocytes - 2

open access: yes, 2010
An image from a bone marrow direct smear under 20X magnification showing a cluster of megakaryocytes in the tail of the ...
Fraser, Marion
core   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Anti-apoptotic BCL2L2 increases megakaryocyte proplatelet formation in cultures of human cord blood

open access: yesHaematologica, 2019
Apoptosis is a recognized limitation to generating large numbers of megakaryocytes in culture. The genes responsible have been rigorously studied in vivo in mice, but are poorly characterized in human culture systems.
Seema Bhatlekar   +10 more
doaj   +1 more source

Large RhoA-null megakaryocytes are less compliant than normal sized megakaryocytes.

open access: yes, 2013
(A) Pictured are representative cells being aspirated with micropipettes (ΔP 0.3–5.7 kPa) causing the cell membrane protrusion (arrows) to extend in length over time.
Yangfeng Wang (436175)   +11 more
core   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

open access: yesMolecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy